Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 2, Pages 594
Publisher
MDPI AG
Online
2020-02-25
DOI
10.3390/jcm9020594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations
- (2020) Stephen Mullin et al. JAMA Neurology
- Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis
- (2019) Sung Min Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- The effect of mutant GBA1 on accumulation and aggregation of α-synuclein
- (2019) Gali Maor et al. HUMAN MOLECULAR GENETICS
- GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson’s disease
- (2019) Masashi Ikuno et al. HUMAN MOLECULAR GENETICS
- Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone
- (2019) Jun Sung Lee et al. BRAIN
- Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study
- (2019) Micol Avenali et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
- (2019) James J. Miller et al. Scientific Reports
- Lipid Metabolism in Late-Onset Alzheimer’s Disease Differs from Patients Presenting with Other Dementia Phenotypes
- (2019) Syena Sarrafpour et al. International Journal of Environmental Research and Public Health
- Progress in the understanding and treatment of Fabry disease
- (2019) James J. Miller et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
- (2019) Silvia Paciotti et al. CLINICA CHIMICA ACTA
- Gentamicin Targets Acid Sphingomyelinase in Cancer: The Case of the Human Gastric Cancer NCI-N87 Cells
- (2019) Elisabetta Albi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
- (2019) Mylene Huebecker et al. Molecular Neurodegeneration
- The vicious cycle between α ‐synuclein aggregation and autophagic‐lysosomal dysfunction
- (2019) Giovanni Bellomo et al. MOVEMENT DISORDERS
- Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
- (2019) Orly Goldstein et al. MOLECULAR GENETICS AND METABOLISM
- Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation
- (2019) Shi-yu Yang et al. NEUROBIOLOGY OF DISEASE
- VDR independent induction of acid-sphingomyelinase by 1,23(OH) 2 D 3 in gastric cancer cells: Impact on apoptosis and cell morphology
- (2018) Elisabetta Albi et al. BIOCHIMIE
- Molecular regulations and therapeutic targets of Gaucher disease
- (2018) Yuehong Chen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment
- (2018) Mel Pilar Espaillat et al. FASEB JOURNAL
- Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
- (2018) Myung Jong Kim et al. HUMAN MOLECULAR GENETICS
- The Many Facets of Sphingolipids in the Specific Phases of Acute Inflammatory Response
- (2018) Sabine Grösch et al. MEDIATORS OF INFLAMMATION
- Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
- (2018) Tim E. Moors et al. MOLECULAR NEUROBIOLOGY
- The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
- (2018) Michael P. Nelson et al. NEUROBIOLOGY OF DISEASE
- Alpha galactosidase A activity in Parkinson's disease
- (2018) R.N. Alcalay et al. NEUROBIOLOGY OF DISEASE
- Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide
- (2018) Friederike Zunke et al. NEURON
- Acid ceramidase deficiency: Farber disease and SMA-PME
- (2018) Fabian P. S. Yu et al. Orphanet Journal of Rare Diseases
- Analysis of age-related changes in psychosine metabolism in the human brain
- (2018) Michael S. Marshall et al. PLoS One
- Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients
- (2018) Damiana Pieragostino et al. Scientific Reports
- Phenotypic Characteristics in GBA-Associated Parkinson’s Disease: A Study in a Greek Population
- (2018) Athina Simitsi et al. Journal of Parkinsons Disease
- The Association between E326K of GBA and the Risk of Parkinson’s Disease
- (2018) Yongpan Huang et al. Parkinsons Disease
- Characterization of small fiber pathology in a mouse model of Fabry disease
- (2018) Lukas Hofmann et al. eLife
- Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy
- (2017) Nienke M. de Wit et al. JOURNAL OF ALZHEIMERS DISEASE
- Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience
- (2017) Barbara K. Burton et al. JOURNAL OF PEDIATRICS
- Types A and B Niemann-Pick disease
- (2017) Edward H. Schuchman et al. MOLECULAR GENETICS AND METABOLISM
- Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
- (2017) Stefanie Lerche et al. MOVEMENT DISORDERS
- Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients
- (2017) Lucilla Parnetti et al. MOVEMENT DISORDERS
- SMPD1 variants in Chinese Han patients with sporadic Parkinson's disease
- (2017) Cheng-yuan Mao et al. PARKINSONISM & RELATED DISORDERS
- A “dose” effect of mutations in the GBA gene on Parkinson's disease phenotype
- (2017) Avner Thaler et al. PARKINSONISM & RELATED DISORDERS
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
- (2016) Joana Magalhaes et al. HUMAN MOLECULAR GENETICS
- Activation of -Glucocerebrosidase Reduces Pathological -Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons
- (2016) J. R. Mazzulli et al. JOURNAL OF NEUROSCIENCE
- Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry
- (2016) Susan Elliott et al. MOLECULAR GENETICS AND METABOLISM
- Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression
- (2016) Albert A. Davis et al. NEUROBIOLOGY OF AGING
- Leukocyte glucocerebrosidase and β-hexosaminidase activity in sporadic and genetic Parkinson disease
- (2016) Han-Joon Kim et al. PARKINSONISM & RELATED DISORDERS
- Acid ceramidase is upregulated in AML and represents a novel therapeutic target
- (2016) Su-Fern Tan et al. Oncotarget
- ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons
- (2016) Hugo J.R. Fernandes et al. Stem Cell Reports
- α-Galactosidase A Knockout Mice
- (2015) Dinesh S. Bangari et al. AMERICAN JOURNAL OF PATHOLOGY
- The molecular medicine of acid ceramidase
- (2015) Michael Frohbergh et al. BIOLOGICAL CHEMISTRY
- Glucocerebrosidase activity in Parkinson’s disease with and withoutGBAmutations
- (2015) Roy N. Alcalay et al. BRAIN
- History, genetic, and recent advances on Krabbe disease
- (2015) Adriana Carol Eleonora Graziano et al. GENE
- Glucocerebrosidase and Parkinson disease: Recent advances
- (2015) Anthony H.V. Schapira MOLECULAR AND CELLULAR NEUROSCIENCE
- Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
- (2015) Davide Chiasserini et al. Molecular Neurodegeneration
- SMPD1 mutations and Parkinson disease
- (2015) E. Dagan et al. PARKINSONISM & RELATED DISORDERS
- The emerging role of SMPD1 mutations in Parkinson's disease: Implications for future studies
- (2015) Ziv Gan-Or et al. PARKINSONISM & RELATED DISORDERS
- Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer’s Disease
- (2015) Alfred N. Fonteh et al. PLoS One
- Cysteine cathepsins are essential in lysosomal degradation of α-synuclein
- (2015) Ryan P. McGlinchey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Krabbe disease
- (2015) N. Sakai DRUGS OF THE FUTURE
- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
- (2014) Karen E. Murphy et al. BRAIN
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- Arylsulphatase A activity in familial parkinsonism: a pathogenetic role?
- (2014) Elena Antelmi et al. JOURNAL OF NEUROLOGY
- Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease
- (2014) Benjamin R Smith et al. JOURNAL OF PATHOLOGY
- Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
- (2014) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Ceramides and sphingomyelinases in senile plaques
- (2014) Maï Panchal et al. NEUROBIOLOGY OF DISEASE
- The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease
- (2014) R.-M. Wu et al. NEUROLOGY
- Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases
- (2014) S.N. Pchelina et al. NEUROSCIENCE LETTERS
- Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice
- (2014) Michael P Nelson et al. Acta Neuropathologica Communications
- A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis
- (2013) Atsumi Taguchi et al. BIOCHEMICAL JOURNAL
- Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort
- (2013) Sophie E. Winder-Rhodes et al. BRAIN
- The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease
- (2013) Z. Gan-Or et al. NEUROLOGY
- Unfolded protein response in Gaucher disease: from human to Drosophila
- (2013) Gali Maor et al. Orphanet Journal of Rare Diseases
- Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes
- (2012) Ruben van Doorn et al. ACTA NEUROPATHOLOGICA
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
- (2012) Gemma Fabrias et al. Anti-Cancer Agents in Medicinal Chemistry
- Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review
- (2012) Rabab Debs et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid- Peptide
- (2012) S. Keilani et al. JOURNAL OF NEUROSCIENCE
- Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury
- (2011) SunJa Kim et al. BRAIN PATHOLOGY
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations
- (2011) Jae Hyuk Choi et al. MOLECULAR GENETICS AND METABOLISM
- Decreased Expression of Lysosomal Alpha-Galactosiase A Gene in Sporadic Parkinson’s Disease
- (2011) Guanghua Wu et al. NEUROCHEMICAL RESEARCH
- CNS expression of glucocerebrosidase corrects -synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
- (2011) S. P. Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arylsulphatase A (ASA) activity in parkinsonism and symptomatic essential tremor
- (2010) P. Martinelli et al. ACTA NEUROLOGICA SCANDINAVICA
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
- (2010) Ozlem Goker-Alpan et al. ACTA NEUROPATHOLOGICA
- Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A)
- (2009) Wuh-Liang Hwu et al. HUMAN MUTATION
- Involvement of Acid β-Glucosidase 1 in the Salvage Pathway of Ceramide Formation
- (2009) Kazuyuki Kitatani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Psychosine Accumulates in Membrane Microdomains in the Brain of Krabbe Patients, Disrupting the Raft Architecture
- (2009) A. B. White et al. JOURNAL OF NEUROSCIENCE
- MUTATIONS IN GBA ARE ASSOCIATED WITH FAMILIAL PARKINSON DISEASE SUSCEPTIBILITY AND AGE AT ONSET
- (2009) E. Sidransky et al. NEUROLOGY
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease
- (2008) Guanghua Wu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started